30-day changes in enteral enzymes were followed up in test and control growing white rats. Test animals received protein- and calorie-deficient feeding. It was established that retardation of growth was more marked in protein than in calorie deficiency.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Prospective evaluation of serum and peritoneal fluid markers as indicators of postoperative complications in patients with enteric anastomosis.
Ann Saudi Med
December 2024
From the Faculty of Medicine, University of Pristina, Medical Statistics and Informatics, Kosovska Mitrovica, Serbia.
Background: Postoperative complications of colorectal cancer surgery contribute to increased morbidity and mortality in patients.
Objectives: Investigate the role of biochemical markers in serum and peritoneal fluid in the development of postoperative complications in patients with enteral anastomosis.
Design: Prospective.
Metabolic bone disease in premature infants receiving parenteral nutrition: Incidence, clinical, laboratory and nutritional profile.
Early Hum Dev
January 2025
Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Programa de Pós-Graduação em Ciências Médicas: Endocrinologia, Porto Alegre, Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Serviço de Neonatologia, Porto Alegre, Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Serviço de Nutrologia, Porto Alegre, Rio Grande do Sul, Brazil. Electronic address:
Background: Metabolic bone disease (MBD) of newborns (NB) is characterized by tissue reduction and inadequate postnatal bone mineralization with clinical, laboratory, and/or radiologic repercussions between the third and twelfth weeks of postnatal life, which, in its most severe forms, can lead to a growth deficit and fractures. The aim of our study is to evaluate the incidence of MBD in premature patients receiving parenteral nutrition for >15 days in the neonatal intensive care unit (NICU) and assess their clinical and laboratory characteristics.
Methods: Single-center retrospective cohort study.
Influence of bovine lactoferrin on feeding intolerance and intestinal permeability in preterm infants: a randomized controlled trial.
Eur J Pediatr
November 2024
Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Article Synopsis
- Preterm infants often experience feeding intolerance due to their immature digestive systems, which can lead to increased risks of complications.
- A study was conducted to evaluate the effects of oral bovine lactoferrin (LF) supplementation on feeding intolerance and intestinal health in these infants, using a randomized double-blind design with 60 preterm neonates.
- Results showed that infants receiving lactoferrin achieved full feeding sooner (9 days vs. 15 days) and had lower serum zonulin levels, indicating improved intestinal permeability and feeding tolerance compared to the control group.
Continuous glucose monitoring (CGM) for effective glucose control in a pregnant woman living with type IIIa glycogenosis. A case report.
Clin Nutr ESPEN
December 2024
Nutrition-Diabetes Department, University Hospital of Montpellier, Montpellier, France; UMR 1302, Institute Desbrest of Epidemiology and Public Health, Univ Montpellier, INSERM, University Hospital of Montpellier, Montpellier, France.
Background & Aims: Glycogenosis type III is a rare autosomal recessive disease caused by a mutation in the AGL gene that results in a deficiency of the glycogen debranching enzyme. This deficiency impairs fasting tolerance and leads to hypoglycemia. While the symptomatology tends to improve with age, pregnancy can trigger a recurrence of hypoglycemia due to increased carbohydrate requirements.
View Article and Find Full Text PDFOptimization of Exocrine Pancreatic Insufficiency in Pancreatic Adenocarcinoma Patients.
Nutrients
October 2024
Division of Surgical Oncology, Department of Surgery, University of Louisville, Louisville, KY 40202, USA.
Article Synopsis
- The study investigates how to better manage exocrine pancreatic insufficiency (EPI) in pancreatic adenocarcinoma patients through treatments like oral pancreatic enzyme replacement therapy (PERT) and immobilized lipase cartridges (RELiZORB) during a specific time frame at Louisville Medical Center.
- EPI symptoms were prevalent in 80% of the 35 patients studied, with many using jejunostomy tubes and enzyme cartridges; those without tubes relied on PERT, both approaches significantly improved patient quality of life.
- The findings emphasize the importance of early EPI management to enhance patient care, facilitate a return to cancer treatment post-surgery, and improve overall quality of life for those undergoing pancreatic
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!